CAPTRUST Financial Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,582
Closed -$39K 2764
2022
Q2
$39K Buy
1,582
+266
+20% +$7.95K ﹤0.01% 2946
2022
Q1
$44K Buy
1,316
+231
+21% +$7.6K ﹤0.01% 2877
2021
Q4
$35K Sell
1,085
-19
-2% -$625 ﹤0.01% 2916
2021
Q3
$39K Sell
1,104
-590
-35% -$23.1K ﹤0.01% 2745
2021
Q2
$70K Sell
1,694
-2,939
-63% -$117K ﹤0.01% 2286
2021
Q1
$171K Buy
4,633
+3,449
+291% +$130K ﹤0.01% 1579
2020
Q4
$49K Buy
1,184
+2
+0.2% +$83 ﹤0.01% 1836
2020
Q3
$49K Buy
1,182
+208
+21% +$8.97K ﹤0.01% 1634
2020
Q2
$43K Buy
+974
New +$38.5K ﹤0.01% 1673

Other funds holding FMS

CAPTRUST Financial Advisors's FMS Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Fresenius Medical Care (FMS) in Q3 2022, closing a stake of 1,582 shares — an estimated $39K sold.

CAPTRUST Financial Advisors first reported a position in FMS in Q2 2020 and held it in 9 quarters. The position peaked at $171K in Q1 2021. 141 funds tracked by Wall St. Rank hold FMS as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Fresenius Medical Care position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,582 Fresenius Medical Care shares in Q3 2022, an estimated $39K.
  • CAPTRUST Financial Advisors first reported a position in Fresenius Medical Care in Q2 2020 and held it in 9 quarters.
  • CAPTRUST Financial Advisors's Fresenius Medical Care position peaked at $171K in Q1 2021.
  • 141 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.